Therapeutics for Moderate and Severe Dengue

NCT07543458 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

8800

Enrollment

OTHER

Sponsor class

Conditions

Dengue
Severe Dengue
Mosquito-Borne Diseases
Vector Borne Diseases
Arbovirus Infections
Flavivirus Infections
RNA Virus Infections
Hemorrhagic Fever

Interventions

DRUG: Placebo
DRUG: Dexamethasone
DRUG: N-Acetylcysteine
OTHER: Standard of care
DRUG: Baricitinib

Sponsor

Oxford University Clinical Research Unit, Vietnam

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]